Compass Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,634
Closed -$674K 113
2025
Q3
$674K Sell
3,634
-48
-1% -$8.22K 0.15% 93
2025
Q2
$562K Hold
3,682
0.13% 100
2025
Q1
$611K Buy
3,682
+460
+14% +$72K 0.16% 92
2024
Q4
$466K Sell
3,222
-100
-3% -$15.5K 0.11% 112
2024
Q3
$538K Sell
3,322
-57
-2% -$9.08K 0.13% 112
2024
Q2
$494K Hold
3,379
0.12% 115
2024
Q1
$535K Hold
3,379
0.13% 111
2023
Q4
$530K Hold
3,379
0.15% 108
2023
Q3
$526K Hold
3,379
0.17% 112
2023
Q2
$559K Hold
3,379
0.17% 108
2023
Q1
$524K Sell
3,379
-171
-5% -$27.6K 0.17% 113
2022
Q4
$627K Buy
+3,550
New +$613K 0.21% 109

Other funds holding JNJ

Compass Wealth Management's JNJ Position: Q4 2025 in Review

Compass Wealth Management sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 3,634 shares — an estimated $674K sold.

Compass Wealth Management first reported a position in JNJ in Q4 2022 and held it in 12 quarters. The position peaked at $674K in Q3 2025. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Compass Wealth Management reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
  • Compass Wealth Management sold 3,634 Johnson & Johnson shares in Q4 2025, an estimated $674K.
  • Compass Wealth Management first reported a position in Johnson & Johnson in Q4 2022 and held it in 12 quarters.
  • Compass Wealth Management's Johnson & Johnson position peaked at $674K in Q3 2025.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Compass Wealth Management's 13F filing for Q4 2025, filed 11 Feb 2026.